Tuesday, March 18, 2014

Vansen Pharma (VNSN) Acquires Canada Health Empire

Specialty pharmaceutical company Vansen Pharma announced it has acquired Ottawa- based Canada Health Empire and its related company 6708595 Canada, Inc. (CHE, collectively), which sell and market a portfolio of natural health products under brands like O2, Zincola, Omega-3 Super Krill Oil, Bone Guard, and Ironex, among others.

In conjunction with the acquisition of CHE, Vansen is acquiring the needed product registrations, trademarks, starting material inventory, manufacturing expertise, import/export permits, and customer information to continue selling and marketing the products in various export markets. The acquisition’s financial terms were not disclosed.

Strong loyalty has developed for CHE’s products among sales and distribution partners, and with the completion of the transaction, Vansen is acquiring a new revenue stream and a platform for developing niche high-margin natural health brands in export markets, which are anticipated to show triple-digit growth over the next few years.

For more information, visit the company’s website at www.vansenpharma.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com


Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html